Based on the recent findings, the CDC will start working to develop guidance on the use of PrEP among heterosexuals in the United States, the agency said.
"To use PrEP in the United States we would use basically the same guidelines -- someone who is truly at risk for HIV," said Dr. Margaret A. Fischl, professor of medicine and director of the AIDS Clinical Research Unit and co-director of the University of Miami Developmental Center for AIDS Research, commenting on the studies released July 13.
Those at high-risk have multiple sex partners, use intravenous drugs or have multiple sexually transmitted diseases, Fischl said. "You are talking about a group that is at risk for multiple sexually transmitted diseases including HIV," she said.
However, it might be difficult to get the drugs to the people who need them, Fischl added.
"In addition, we need to identify people with HIV and get them into care, because in doing that we know that we decrease the transmission of HIV," Fischl said.
For more information on HIV/AIDS, visit AIDS.gov.
SOURCES: July 18, 2011, New England Journal of Medicine, online; Margaret A. Fischl, M.D., professor, medicine, director, AIDS Clinical Research Unit, co-director, University of Miami Developmental Center for AIDS Research; July 13, 2011, teleconference with Jared Baeten, M.D., Ph.D., associate professor, global health, University of Washington
All rights reserved